Cargando…

Rationalization of Activity Cliffs of a Sulfonamide Inhibitor of DNA Methyltransferases with Induced-Fit Docking

Inhibitors of human DNA methyltransferases (DNMT) are of increasing interest to develop novel epi-drugs for the treatment of cancer and other diseases. As the number of compounds with reported DNMT inhibition is increasing, molecular docking is shedding light to elucidate their mechanism of action a...

Descripción completa

Detalles Bibliográficos
Autores principales: Medina-Franco, José L., Méndez-Lucio, Oscar, Yoo, Jakyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3958909/
https://www.ncbi.nlm.nih.gov/pubmed/24566147
http://dx.doi.org/10.3390/ijms15023253
_version_ 1782307969019412480
author Medina-Franco, José L.
Méndez-Lucio, Oscar
Yoo, Jakyung
author_facet Medina-Franco, José L.
Méndez-Lucio, Oscar
Yoo, Jakyung
author_sort Medina-Franco, José L.
collection PubMed
description Inhibitors of human DNA methyltransferases (DNMT) are of increasing interest to develop novel epi-drugs for the treatment of cancer and other diseases. As the number of compounds with reported DNMT inhibition is increasing, molecular docking is shedding light to elucidate their mechanism of action and further interpret structure–activity relationships. Herein, we present a structure-based rationalization of the activity of SW155246, a distinct sulfonamide compound recently reported as an inhibitor of human DNMT1 obtained from high-throughput screening. We used flexible and induce-fit docking to develop a binding model of SW155246 with a crystallographic structure of human DNMT1. Results were in excellent agreement with experimental information providing a three-dimensional structural interpretation of ‘activity cliffs’, e.g., analogues of SW155246 with a high structural similarity to the sulfonamide compound, but with no activity in the enzymatic assay.
format Online
Article
Text
id pubmed-3958909
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Molecular Diversity Preservation International (MDPI)
record_format MEDLINE/PubMed
spelling pubmed-39589092014-03-20 Rationalization of Activity Cliffs of a Sulfonamide Inhibitor of DNA Methyltransferases with Induced-Fit Docking Medina-Franco, José L. Méndez-Lucio, Oscar Yoo, Jakyung Int J Mol Sci Communication Inhibitors of human DNA methyltransferases (DNMT) are of increasing interest to develop novel epi-drugs for the treatment of cancer and other diseases. As the number of compounds with reported DNMT inhibition is increasing, molecular docking is shedding light to elucidate their mechanism of action and further interpret structure–activity relationships. Herein, we present a structure-based rationalization of the activity of SW155246, a distinct sulfonamide compound recently reported as an inhibitor of human DNMT1 obtained from high-throughput screening. We used flexible and induce-fit docking to develop a binding model of SW155246 with a crystallographic structure of human DNMT1. Results were in excellent agreement with experimental information providing a three-dimensional structural interpretation of ‘activity cliffs’, e.g., analogues of SW155246 with a high structural similarity to the sulfonamide compound, but with no activity in the enzymatic assay. Molecular Diversity Preservation International (MDPI) 2014-02-21 /pmc/articles/PMC3958909/ /pubmed/24566147 http://dx.doi.org/10.3390/ijms15023253 Text en © 2014 by the authors; licensee MDPI, Basel, Switzerland http://creativecommons.org/licenses/by/3.0/ This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Communication
Medina-Franco, José L.
Méndez-Lucio, Oscar
Yoo, Jakyung
Rationalization of Activity Cliffs of a Sulfonamide Inhibitor of DNA Methyltransferases with Induced-Fit Docking
title Rationalization of Activity Cliffs of a Sulfonamide Inhibitor of DNA Methyltransferases with Induced-Fit Docking
title_full Rationalization of Activity Cliffs of a Sulfonamide Inhibitor of DNA Methyltransferases with Induced-Fit Docking
title_fullStr Rationalization of Activity Cliffs of a Sulfonamide Inhibitor of DNA Methyltransferases with Induced-Fit Docking
title_full_unstemmed Rationalization of Activity Cliffs of a Sulfonamide Inhibitor of DNA Methyltransferases with Induced-Fit Docking
title_short Rationalization of Activity Cliffs of a Sulfonamide Inhibitor of DNA Methyltransferases with Induced-Fit Docking
title_sort rationalization of activity cliffs of a sulfonamide inhibitor of dna methyltransferases with induced-fit docking
topic Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3958909/
https://www.ncbi.nlm.nih.gov/pubmed/24566147
http://dx.doi.org/10.3390/ijms15023253
work_keys_str_mv AT medinafrancojosel rationalizationofactivitycliffsofasulfonamideinhibitorofdnamethyltransferaseswithinducedfitdocking
AT mendezluciooscar rationalizationofactivitycliffsofasulfonamideinhibitorofdnamethyltransferaseswithinducedfitdocking
AT yoojakyung rationalizationofactivitycliffsofasulfonamideinhibitorofdnamethyltransferaseswithinducedfitdocking